Literature DB >> 4146782

Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.

N K Sood, C W Havard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146782      PMCID: PMC470037          DOI: 10.1136/thx.28.3.331

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  20 in total

1.  USE OF PROPRANOLOL IN ANGINA PECTORIS.

Authors:  P M GILLAM; B N PRICHARD
Journal:  Br Med J       Date:  1965-08-07

2.  Unwanted effects of propranolol.

Authors:  S A Stephen
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.

Authors:  R E Cole; R I Goldberg
Journal:  Curr Ther Res Clin Exp       Date:  1967-11

5.  Effects of I.C.I. 50172 in man during erect exercise.

Authors:  D Gibson; E Sowton
Journal:  Br Med J       Date:  1968-01-27

6.  Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease.

Authors:  E Sowton; R Balcon; D Cross; H Frick
Journal:  Br Med J       Date:  1968-01-27

7.  Some haemodynamic effects of trasicor (Ciba 39,089-Ba).

Authors:  D F Wilson; O F Watson; J S Peel; R B Langley; A S Turner
Journal:  N Z Med J       Date:  1968-09

8.  Trasicor (39,089/Ba) in angina pectoris. A single-blind trial.

Authors:  D F Wilson; A S Turner
Journal:  N Z Med J       Date:  1968-03

9.  Propranolol and angina pectoris.

Authors:  S Wolfson; R A Heinle; M V Herman; H G Kemp; J M Sullivan; R Gorlin
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Trasicor in angina pectoris: a double-blind trial.

Authors:  D F Wilson; O F Watson; J S Peel; A S Turner
Journal:  Br Med J       Date:  1969-04-19
View more
  2 in total

1.  Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.

Authors:  I Nordenfelt; L Olsson; S Persson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

2.  Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.

Authors:  G Jackson; L Atkinson; S Oram
Journal:  Br Med J       Date:  1975-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.